Skip to content

Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes

Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02473926
Enrollment
55
Registered
2015-06-17
Start date
2015-12-31
Completion date
2019-07-29
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Health Behavior, Motor Activity

Keywords

Physical Activity, Physical Function, Physical Impairment, Sedentary Lifestyle

Brief summary

This study plans to learn more about physical activity and physical function in sedentary older adults with type 2 diabetes.

Detailed description

The purpose of this study is to conduct a randomized controlled trial with 1:1 patient-level randomization to an evidence-based physical activity program intervention versus usual care in sedentary older adults with type 2 diabetes in two primary care clinic sites.

Interventions

BEHAVIORALPhysical Activity

Physical Activity Program Intervention

BEHAVIORALQuestionnaires

Participants in the usual care arm will receive three mailings during the intervention phase.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of type 2 diabetes * Sedentary individual, performing \<20 minutes of physical activity on \<3 days/week

Exclusion criteria

* Dementia (Folstein Mini-Mental Status Exam \<24) or clinical diagnosis * Excessive fall risk: Can not hold semi-tandem stance for \>10 seconds * Type 2 diabetes-related safety concerns: Prior diabetic foot ulcer, Charcot foot, asymptomatic hypoglycemia * Severely uncontrolled hypertension (BP \>180/100) * Excessive hearing or visual impairment for counseling * Limited life expectancy: Active treatment for malignancy * Performs regular physical activity \>20 minutes on \>3 days/week

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Objective Physical Activity at 4 MonthsBaseline, 4 MonthsActiGraph accelerometer measures physical activity objectively as steps/week. These data are presented as the change from baseline values.

Secondary

MeasureTime frameDescription
Change From Baseline in Physical Function at 4 MonthsBaseline, 4 MonthsMeasured via 400-meter rapid gait speed test. These data are presented as the change from baseline values, where decrease in numbers indicate a faster walking speed.

Countries

United States

Participant flow

Recruitment details

A total of 55 people were determined to be eligible for this study, however 5 of them withdrew prior to randomization. This explains the discrepancy between Protocol section (n=55) and Participant Flow Module (n=50).

Participants by arm

ArmCount
Physical Activity Program Intervention
The intervention seeks to increase physical activity and improve strength by addressing individual , behavioral, and social/environmental factors. Health promotion clinic staff will deliver counseling by phone on a bi-weekly basis - a clinic physician assistant will coordinate with the counselor during in-person clinic visits, teach participants to perform strengthening exercise, and assess for safety concerns associated with type 2 diabetes. In addition to behavioral counseling targeting social cognitive theory constructs, counselors will assist participants in the intervention group to set specific goals for physical activity in a paper log and on an electronic FitBit activity tracking device.Health promotion clinic staff will encourage participants to advance goals towards meeting U.S. physical activity guidelines of 150 minutes/week of moderate intensity activity and 2-3 days/week of strength activities. Physical Activity: Physical Activity Program Intervention
28
Usual Care Group
Participants in the usual care arm will receive three mailings (Intervention Questionnaires) during the intervention phase. Health promotion clinic staff will mail materials from the Center for Disease Control and Prevention website that address general health aging topics. Questionnaires: Participants in the usual care arm will receive three mailings during the intervention phase.
22
Total50

Baseline characteristics

CharacteristicTotalPhysical Activity Program InterventionUsual Care Group
Age, Continuous66.5 years
STANDARD_DEVIATION 7.4
65.5 years
STANDARD_DEVIATION 7.6
66.5 years
STANDARD_DEVIATION 7.1
Baseline fitness level (VO2peak, ml/kg/min)18.4 ml/kg/min
STANDARD_DEVIATION 4.4
18.5 ml/kg/min
STANDARD_DEVIATION 4.7
18.3 ml/kg/min
STANDARD_DEVIATION 3
Body Mass Index (kg/m^2)32.1 kg/m^2
STANDARD_DEVIATION 6.4
32.8 kg/m^2
STANDARD_DEVIATION 6
31.6 kg/m^2
STANDARD_DEVIATION 6.7
Confidence: Motivation to conduct physical activity(PA) amidst competing demands41.7 points
STANDARD_DEVIATION 11.9
41.2 points
STANDARD_DEVIATION 9.8
43.8 points
STANDARD_DEVIATION 8.6
Confidence: Self-efficacy for physical activity in presence of diabetes588.8 points
STANDARD_DEVIATION 153.2
592.1 points
STANDARD_DEVIATION 158.6
587.3 points
STANDARD_DEVIATION 183.2
Depressive symptoms by Center for Epidemiologic Studies Depression Scale (CES-D)10.2 points
STANDARD_DEVIATION 8.2
10.3 points
STANDARD_DEVIATION 8.3
10.2 points
STANDARD_DEVIATION 8.3
Diastolic Blood Pressure (mm/Hg)82.0 mm/Hg
STANDARD_DEVIATION 8.5
83.6 mm/Hg
STANDARD_DEVIATION 8.6
80.0 mm/Hg
STANDARD_DEVIATION 8.1
Endurance Confidence Survey682.8 points
STANDARD_DEVIATION 345.8
695.0 points
STANDARD_DEVIATION 372.7
584.1 points
STANDARD_DEVIATION 288.9
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants2 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants26 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Hemoglobin A1c (%)6.8 percent
STANDARD_DEVIATION 1.1
6.9 percent
STANDARD_DEVIATION 1.3
6.7 percent
STANDARD_DEVIATION 0.8
% participants with baseline functional impairment34 Participants17 Participants17 Participants
Race/Ethnicity, Customized
Alaskan Native/Native American
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Asian
3 Participants2 Participants1 Participants
Race/Ethnicity, Customized
Black/African American
14 Participants10 Participants4 Participants
Race/Ethnicity, Customized
Hispanic
7 Participants2 Participants5 Participants
Race/Ethnicity, Customized
White/Caucasian
25 Participants13 Participants12 Participants
Region of Enrollment
United States
50 participants28 participants22 participants
Sex: Female, Male
Female
26 Participants13 Participants13 Participants
Sex: Female, Male
Male
24 Participants15 Participants9 Participants
Systolic Blood Pressure (mm/Hg)127.0 mm/Hg
STANDARD_DEVIATION 9.9
128.1 mm/Hg
STANDARD_DEVIATION 9.4
125.6 mm/Hg
STANDARD_DEVIATION 10.5
Weight (kg)91.2 kilograms
STANDARD_DEVIATION 47
92.0 kilograms
STANDARD_DEVIATION 21.4
90.6 kilograms
STANDARD_DEVIATION 21.7

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 280 / 22
other
Total, other adverse events
3 / 280 / 22
serious
Total, serious adverse events
0 / 280 / 22

Outcome results

Primary

Change From Baseline in Objective Physical Activity at 4 Months

ActiGraph accelerometer measures physical activity objectively as steps/week. These data are presented as the change from baseline values.

Time frame: Baseline, 4 Months

ArmMeasureValue (MEAN)
Physical Activity Program InterventionChange From Baseline in Objective Physical Activity at 4 Months3155 steps/week
Usual Care GroupChange From Baseline in Objective Physical Activity at 4 Months1581 steps/week
Secondary

Change From Baseline in Physical Function at 4 Months

Measured via 400-meter rapid gait speed test. These data are presented as the change from baseline values, where decrease in numbers indicate a faster walking speed.

Time frame: Baseline, 4 Months

ArmMeasureValue (MEAN)
Physical Activity Program InterventionChange From Baseline in Physical Function at 4 Months-23.4 seconds
Usual Care GroupChange From Baseline in Physical Function at 4 Months7.3 seconds
Secondary

Change From Baseline in Physical Function at 4 Months

Measured via the Short Physical Performance Battery (SPPB), which evaluates balance, usual walking speed, and repeated chair rise. These data are presented as the change from baseline values where higher values indicate better physical function (scoring range 0-12).

Time frame: Baseline, 4 Months

ArmMeasureValue (MEAN)
Physical Activity Program InterventionChange From Baseline in Physical Function at 4 Months0.9 units on a scale
Usual Care GroupChange From Baseline in Physical Function at 4 Months-0.1 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026